← Back to contracts

NCI Cancer Screening Research Network: Coordinating and Communication Center

US · IL National Cancer Institute (NCI), National Institutes of Health (NIH) grant open #nih-5UG1CA286954-02

Summary

The National Cancer Institute (NCI) is establishing a Cancer Screening Research Network (CSRN) with a Communication and Coordinating Center (CCC) to design and conduct a randomized controlled feasibility trial of multicancer detection (MCD) tests and build infrastructure for future screening studies.

What they want

The CSRN Communication and Coordinating Center (CCC), in conjunction with the CSRN Statistics and Data Management Center (SDMC) and the NCI, will lead and support a national effort to evaluate multicancer detection (MCD) technologies. This involves providing scientific and clinical expertise for designing and implementing multicenter cancer screening trials, particularly randomized trials evaluating MCD assays. The CCC will also develop the organizational structure and administrative relationships for the CSRN, maintain effective communication channels and materials, and support CSRN ACCESS sites in recruitment and retention efforts. The primary goal for the Vanguard phase is to design and conduct a randomized controlled feasibility trial of two promising MCD tests, ultimately assessing feasibility and establishing core infrastructure for future full-scale trials and observational studies of MCD tests and other cancer screening approaches.
Deliverables
  • Design and implementation of multicenter cancer screening trials, especially randomized trials evaluating MCD assays
  • Organizational structure and administrative relationships for CSRN
  • Effective communication channels and materials
  • Support for CSRN ACCESS sites in recruitment and retention
  • A randomized controlled feasibility trial of two promising MCD tests
  • Infrastructure, data, and learnings to support full-scale trials and additional observational studies

Market context

inferred from NAICS
R&D in Physical, Engineering, Life Sciences (except Nanotech & Biotech)
NAICS 541715
US market size
$95B
Typical award
$100K – $50M+
Typical buyers
DoDNSFNIHNASADOE
Commonly required
DCAA-compliant accountingITARCMMC L2
NCI Cancer Screening Research Network: Coo…
Onboard